AUF CRISPR-EFFEKTOR-SYSTEM BASIERENDE DIAGNOSE
European patent · EP3551753 · In force
Register entry
- Publication number
- EP3551753
- Application number
- EP17879489
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 8, 2017
- Published
- Oct 16, 2019
- Granted
- Jun 29, 2022
- Protection ends at the latest
- Dec 7, 2037
- Next annual fee due
- Dec 31, 2026
- IPC classes
- C12N 15/09 (2006.01)C12N 15/10 (2006.01)C12N 15/11 (2006.01)C12Q 1/68 (2018.01)C12Q 1/6816 (2018.01)C12Q 1/6811 (2018.01)
- Priority
- US 201662432553 P 09.12.2016US 201762456645 P 08.02.2017US 201762471930 P 15.03.2017US 201762484869 P 12.04.2017US 201762568268 P 04.10.2017
- PCT application
- PCT/US2017/065477 08.12.2017
- PCT publication
- WO2018/107129 14.06.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jan 8, 2025
Change
Published in Swissreg on 08.01.2025
- Feb 7, 2024
Change
Published in Swissreg on 07.02.2024
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Oct 18, 2023
Change
Published in Swissreg on 18.10.2023
- Jan 10, 2023
Change
Published in Swissreg on 10.01.2023
- Oct 19, 2022
Change
Published in Swissreg on 19.10.2022
- Jul 28, 2022
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 28.07.2022
1 earlier entry
- Jun 29, 2022
Granted
Published in Swissreg on 29.06.2022
Parties
Holder
Inventor
Cambridge, MA 02138, US
Cambridge, MA 02142, US
Cambridge, MA 02142, US
Cambridge, MA 02139, US
Cambridge, MA 02139, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.